On Thursday, March 26, Kevin Elias, MD, Marc Goodman, Phd, MPH and Douglas A. Levine, MD hosted a Town Hall about COVID-19 followed by a Q&A with our listeners.
Please note that no information shared during this Town Hall is intended to take the place of personal medical advice.
If you have any questions that were not addressed in this Town Hall, or have suggestions for topics you would like to see covered in our next Town Hall, please email email@example.com.
Kevin Elias, MD, Brigham & Women’s Hospital, Tina’s Wish Researcher, fellowship in Intensive Care Medicine, currently serving in Brigham & Women’s COVID-19 ICU unit
Marc Goodman, PhD, MPH, Cedars-Sinai, Tina’s Wish Scientific Advisory Board, Epidemiologist
Douglas A. Levine, MD, NYU Perlmutter Cancer Center, Tina’s Wish Scientific Advisory Board Chair, part of the NYU COVID-19 planning team
Topics covered during the Town Hall Webinar
- Introduction to COVID-19
- How is this different than the flu? How is it different than other pandemics?
- What are the symptoms?Are there different symptoms for cancer patients?
- Who is most at risk and what happens to severe patients?
- Has the younger population shown severe cases?
- What are some preventative behaviors everyone should be practicing?
- What does “flattening the curve” mean & how can we achieve it?
- What is the difference between isolation/self-quarantine/social distancing?
- With so many people testing positive, do I need to get tested if I show symptoms?
- Are home testing kits available and if so, are they reliable?
- Will a vaccine become available any time soon?
- What about the treatments being tested? How soon might we see these available?
- Are there special precautions/different actions that cancer patients need to take or put into place?
- How do cancer survivors know if they are still immunocompromised?
- What are the chances of reinfection?